Sinopharm
1099.HK
#2226
Rank
ยฃ6.18 B
Marketcap
ยฃ1.98
Share price
0.49%
Change (1 day)
-0.56%
Change (1 year)
The Sinopharm Group is a Chinese pharmaceutical company that researches, develops, produces, sells and markets pharmaceuticals and other health products.

Revenue for Sinopharm (1099.HK)

Revenue in 2024: ยฃ60.07 Billion

According to Sinopharm's latest financial reports the company's current revenue (TTM ) is ยฃ60.07 Billion. In 2024 the company made a revenue of ยฃ60.07 Billion a decrease over the revenue in the year 2023 that were of ยฃ63.30 Billion. The revenue is the total amount of income that a company generates by the sale of goods or services. Unlike with the earnings no expenses are subtracted.

Revenue history for Sinopharm from 2006 to 2024

Annual revenue

Year Revenue Change
2024ยฃ60.07 B-5.1%
2023ยฃ63.30 B5.42%
2022ยฃ60.04 B-2.1%
2021ยฃ61.33 B16.85%
2020ยฃ52.48 B14.95%
2019ยฃ45.66 B21.52%
2018ยฃ37.57 B5.93%
2017ยฃ35.47 B27.22%
2016ยฃ27.88 B5.37%
2015ยฃ26.46 B9.14%
2014ยฃ24.24 B17.22%
2013ยฃ20.68 B25.94%
2012ยฃ16.42 B34.61%
2011ยฃ12.19 B55.34%
2010ยฃ7.85 B35.79%
2009ยฃ5.78 B37.56%
2008ยฃ4.20 B31.43%
2007ยฃ3.19 B40.26%
2006ยฃ2.28 B